| Literature DB >> 29780243 |
Tsuneaki Kenzaka1,2, Ayako Kumabe2, Koki Kosami2, Yuki Ueda2, Takeshi Takahashi3, Yuya Yamamoto4, Yurika Hayashi4, Akihito Kitao4, Masanobu Okayama5.
Abstract
PURPOSE: The aim of this study was to investigate whether the day of starting oral intake affects the clinical course of patients with aspiration pneumonia.Entities:
Keywords: discontinuation of oral intake; health economics; hospital duration; weekend
Mesh:
Year: 2018 PMID: 29780243 PMCID: PMC5951128 DOI: 10.2147/CIA.S161786
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Study flowchart.
Summary of the clinical course of starting oral intake on each day of the week
| Variable | Sunday | Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Total |
|---|---|---|---|---|---|---|---|---|
| Patients | 39 (9.9) | 34 (8.7) | 62 (15.8) | 70 (17.9) | 63 (16.1) | 65 (16.6) | 59 (15.1) | 392 (100.0) |
| Hospital duration (days) | 14.7 ± 12.2 | 23.3 ± 24.5 | 24.4 ± 28.5 | 24.4 ± 20.7 | 25.7 ± 24.8 | 27.4 ± 20.5 | 16.5 ± 8.8 | 22.9 ± 21.5 |
| Time from hospitalization to starting oral intake (days) | 2.6 ± 3.6 | 3.7 ± 3.4 | 5.0 ± 4.8 | 4.7 ± 5.9 | 4.2 ± 6.9 | 6.0 ± 6.9 | 3.3 ± 3.2 | 4.4 ± 5.5 |
| Discontinuation of oral intake due to aspiration | 2 (5.1) | 8 (23.5) | 11 (17.7) | 17 (24.3) | 19 (30.2) | 18 (27.7) | 5 (8.5) | 80 (20.4) |
| Deaths | 5 (12.8) | 1 (2.9) | 7 (11.3) | 7 (10.0) | 6 (9.5) | 13 (20.0) | 5 (8.5) | 44 (11.2) |
Note: Data are presented as mean ± SD or number (%).
Figure 2Histogram of the number of admissions per day according to the time from hospitalization to oral intake.
Comparison of measurements between the two groups
| Variable | Weekend group
| Midweek group
| |
|---|---|---|---|
| (n = 98) | (n = 294) | ||
| Age (years) | 79.2 ± 13.4 | 79.4 ± 13.1 | 0.880 |
| Sex (male) | 66 (67.3) | 178 (60.5) | 0.229 |
| Comorbidities | |||
| Tumor of the head and neck | 4 (4.1) | 13 (4.4) | 0.574 |
| History of gastroesophageal surgery | 7 (7.1) | 298 (9.5) | 0.474 |
| Cerebral nerve disease | 54 (55.1) | 169 (57.5) | 0.680 |
| Chronic lower respiratory disease | 21 (21.4) | 47 (16.0) | 0.218 |
| Diabetes mellitus | 9 (9.2) | 38 (12.9) | 0.323 |
| ECOG PS (≥3) | 60 (61.2) | 197 (67.0) | 0.297 |
| Reduced level of consciousness (GCS score) | 13.4 ± 2.3 | 13.9 ± 1.9 | 0.092 |
| Reduced level of consciousness (GCS score ≤14) | 35 (35.7) | 138 (46.9) | 0.053 |
| SpO2 (%) | 87.4 ± 12.3 | 87.0 ± 11.8 | 0.853 |
| SpO2 (≤90.0%) | 55 (56.1) | 166 (56.5) | 0.953 |
| CURB-65 score | 2.1 ± 1.1 | 2.3 ± 1.1 | 0.223 |
| CURB-65 score (≥3) | 33 (37.1) | 103 (39.9) | 0.636 |
| A-DROP score | 2.4 ± 1.1 | 2.5 ± 1.1 | 0.212 |
| A-DROP score (≥3) | 44 (44.9) | 151 (52.7) | 0.180 |
| Shadow in >67.0% of the unilateral lung on chest radiograph | 14 (14.3) | 47 (16.0) | 0.688 |
| WBC count (×103/µL) | 11.0 ± 5.1 | 11.3 ± 5.5 | 0.633 |
| WBC count (≥12.0 × 103/µL) | 37 (37.8) | 112 (38.1) | 0.952 |
| Albumin level (g/dL) | 3.1 ± 0.7 | 3.0 ± 0.6 | 0.278 |
| Albumin level (≤2.5 g/dL) | 13 (14.0) | 51 (18.5) | 0.322 |
| CRP level (mg/dL) | 10.8 ± 8.5 | 10.0 ± 9.2 | 0.439 |
| CRP level (≥10.0 mg/dL) | 48 (49.0) | 112 (38.4) | 0.064 |
| Presence of bacteremia | 3 (3.4) | 6 (2.5) | 0.443 |
| Ventilator use | 1 (1.0) | 12 (4.1) | 0.122 |
| Time from admission to intake (days) | 3.1 ± 3.4 | 4.9 ± 6.0 | ,0.001 |
| Time from admission to intake (≤3 days) | 61 (67.0) | 155 (53.3) | 0.021 |
| Time from admission to intake (≤7 days) | 85 (93.4) | 236 (81.1) | 0.005 |
| Discontinuation of intake | 7 (7.2) | 73 (24.9) | <0.001 |
| Duration of hospitalization (days) | 15.8 ± 10.3 | 25.3 ± 23.7 | <0.001 |
| In-hospital death | 10 (10.2) | 34 (11.6) | 0.712 |
Note: Data are presented as mean ± SD or number (%).
Abbreviations: CRP, C-reactive protein; ECOG, Eastern Cooperative Oncology Group; GCS, Glasgow Coma Scale; PS, performance status; SpO2, blood oxygen saturation; WBC, white blood cell.
Multivariate analysis using duration of hospitalization as the dependent variable
| Variable | B (95% CI) | ||
|---|---|---|---|
| Age (years) | −0.097 | −0.159 (−0.341 to 0.230) | 0.087 |
| Reduced level of consciousness (GCS score ≤14) | 0.036 | 1.550 (−3.997 to 7.096) | 0.583 |
| ECOG PS (≥3) | 0.054 | 2.469 (−2.649 to 7.568) | 0.344 |
| Presence of bacteremia | −0.034 | −4.530 (−19.378 to 10.318) | 0.549 |
| Shadow in >67.0% of the unilateral lung on chest radiograph | 0.081 | 4.822 (−1.968 to 11.612) | 0.163 |
| Albumin level (≤2.5 g/dL) | 0.100 | 5.669 (−0.627 to 11.965) | 0.077 |
| CURB-65 score (≥3) | 0.037 | 1.609 (−4.226 to 7.445) | 0.558 |
| Ventilator use | 0.191 | 22.921 (9.587 to 36.255) | 0.001 |
| Time from admission to intake (≤3 days) | −0.184 | −7.979 (−12.850 to −3.107) | 0.001 |
| Weekend group | −0.141 | −5.333 (−9.626 to −1.040) | 0.011 |
Note: Weekend group restarted oral intake on Saturdays or Sundays.
Abbreviations: ECOG, Eastern Cooperative Oncology Group; GCS, Glasgow Coma Scale; PS, performance status.
Multivariate analysis using discontinuation of oral intake due to aspiration as the dependent variable
| Variable | OR | 95% CI | |
|---|---|---|---|
| Age (≥80 years) | 1.202 | 0.611–2.367 | 0.594 |
| Reduced level of consciousness (GCS score ≤14) | 2.323 | 1.117–4.833 | 0.024 |
| ECOG PS (≥3) | 1.384 | 0.655–2.924 | 0.395 |
| Presence of bacteremia | 0.581 | 0.097–3.484 | 0.553 |
| Shadow in >67% of the unilateral lung on chest radiograph | 3.059 | 1.316–7.111 | 0.009 |
| Albumin level (≤2.5 g/dL) | 2.053 | 0.955–4.416 | 0.066 |
| CURB-65 score (≥3) | 0.698 | 0.322–1.515 | 0.364 |
| Ventilator use | 1.739 | 0.375–8.067 | 0.480 |
| Time from admission to intake (≤3 days) | 0.501 | 0.252–0.998 | 0.049 |
| Weekend group | 0.189 | 0.064–0.559 | 0.003 |
Note: Weekend group restarted oral intake on Saturdays and Sundays.
Abbreviations: ECOG, Eastern Cooperative Oncology Group; GCS, Glasgow Coma Scale; OR, odds ratio; PS, performance status.